Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 8
Original Research
Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm, multicenter study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,378 | Dovepress* | 7,181+ | 1,044 | 8,225 | |
| PubMed Central* | 1,197 | 528 | 1,725 | ||
| Totals | 8,378 | 1,572 | 9,950 | ||
| *Since 7 December 2016 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar